STOP CSUA: phySical acTivity, mOod and sleeP in Chronic Spontaneous Urticaria and Angioedema
STOP CSUA
1 other identifier
observational
40
1 country
1
Brief Summary
Chronic spontaneous urticaria and angioedema (CSUA) is a disease of the skin characterised by hives, swellings or both that last longer than 6 weeks. People with this disease commonly describe poor sleep, reduced quality of life and psychological difficulties such as depression and anxiety. This study seeks to understand relationships between physical activity, sleep and symptoms of urticaria. We are asking individuals with urticaria to wear a fitbit tracker which monitors their physical activity and sleep. Participants also download an app onto their smartphone called Athena CX which is designed by the study team in DCU. The purpose of the app is capture real-time information from participants on mood and any skin symptoms they experience. We will use this information to learn more about possible links between symptoms of urticaria and lifestyle behaviours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2021
CompletedFirst Posted
Study publicly available on registry
December 27, 2021
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedDecember 27, 2021
December 1, 2021
7 months
December 13, 2021
December 13, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Physical activity
Step count as measured by fitbit
Followed for 12 weeks during programme
Urticaria symptomatology
Urticaria control test score
Followed for 12 weeks during programme
Heart rate variability
Heart rate variability
Followed for 12 weeks during programme
Study Arms (1)
CSUA patients
CSUA patients
Interventions
This is an observational study. There is no intervention outside the collection of data from participants. Consenting participants in the study will be provided with a Fitbit activity tracker and asked to wear it for a period of three months. The Fitbit measures: * Physical activity using daily step count * Additional physical activity entries * Heart rate * Sleep quality * Calories burned * Food log Participants will be asked to download an app onto their smart phone entitled Athena CX. This app is designed to capture: * Urticaria symptomatology using the urticaria control test * Symptoms of depression using 2 items from the PHQ 9 * Symptoms of anxiety using two items from the GAD * Short form self-compassion scale
Eligibility Criteria
Chronic spontaneous urticaria clinic
You may qualify if:
- Clinical diagnosis of chronic spontaneous urticaria with or without angioedema
- Urticaria control test score \< 12 indicating poorly controlled urticaria at time of consent
- Preference to participate in the study
- In possession of a smartphone
You may not qualify if:
- Unable or unwilling to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. James's Hospital
Dublin, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Niall Conlon
St. James's Hospital, Ireland
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Immunology specialist registrar
Study Record Dates
First Submitted
December 13, 2021
First Posted
December 27, 2021
Study Start
February 1, 2022
Primary Completion
September 1, 2022
Study Completion
February 1, 2023
Last Updated
December 27, 2021
Record last verified: 2021-12